Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (2) | Back to Search
NEW PHARMACEUTICAL ANTI-COUNTERFEITING SYSTEMS: A COMPARATIVE ASSESSMENT
- In: Poster Session
- At: Düsseldorf (Germany) (2015)
- Type: Poster
- By: MENDES, Bruno (School of Sciences and Health Technologies of University Lusófona, Quality & Health Strategy, Lisboa, Portugal)
- Co-author(s): Alexandre Campos
- Abstract:
The pharmaceutical counterfeiting has a direct and indirect cost of €9,5 – 116 billions, taking near 30% of market share in developing countries. This growth is nowadays correlated with the non-usage of anti-counterfeiting systems (ACS) and with outdated legislation. This issue takes a larger proportion derived from the object of counterfeiting -
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023